CERAGON NETWORKS LTD (CRNT) Fundamental Analysis & Valuation

NASDAQ:CRNT • IL0010851660

Current stock price

2.225 USD
+0.04 (+1.6%)
Last:

This CRNT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. CRNT Profitability Analysis

1.1 Basic Checks

  • In the past year CRNT was profitable.
  • CRNT had a positive operating cash flow in the past year.
  • In multiple years CRNT reported negative net income over the last 5 years.
  • In multiple years CRNT reported negative operating cash flow during the last 5 years.
CRNT Yearly Net Income VS EBIT VS OCF VS FCFCRNT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

  • CRNT has a Return On Assets (0.43%) which is in line with its industry peers.
  • CRNT has a Return On Equity (0.81%) which is in line with its industry peers.
  • Looking at the Return On Invested Capital, with a value of 6.90%, CRNT is in the better half of the industry, outperforming 78.72% of the companies in the same industry.
Industry RankSector Rank
ROA 0.43%
ROE 0.81%
ROIC 6.9%
ROA(3y)0.75%
ROA(5y)-1.82%
ROE(3y)0.89%
ROE(5y)-3.97%
ROIC(3y)N/A
ROIC(5y)N/A
CRNT Yearly ROA, ROE, ROICCRNT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

  • Looking at the Profit Margin, with a value of 0.38%, CRNT is in line with its industry, outperforming 53.19% of the companies in the same industry.
  • Looking at the Operating Margin, with a value of 6.32%, CRNT is in the better half of the industry, outperforming 72.34% of the companies in the same industry.
  • In the last couple of years the Operating Margin of CRNT has grown nicely.
  • With a Gross Margin value of 34.98%, CRNT is not doing good in the industry: 63.83% of the companies in the same industry are doing better.
  • CRNT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.32%
PM (TTM) 0.38%
GM 34.98%
OM growth 3Y71.41%
OM growth 5Y22.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.77%
GM growth 5Y0.06%
CRNT Yearly Profit, Operating, Gross MarginsCRNT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

3

2. CRNT Health Analysis

2.1 Basic Checks

  • CRNT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • There is no outstanding debt for CRNT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CRNT Yearly Shares OutstandingCRNT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CRNT Yearly Total Debt VS Total AssetsCRNT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • Based on the Altman-Z score of 1.41, we must say that CRNT is in the distress zone and has some risk of bankruptcy.
  • CRNT's Altman-Z score of 1.41 is in line compared to the rest of the industry. CRNT outperforms 53.19% of its industry peers.
  • CRNT has a debt to FCF ratio of 7.68. This is a slightly negative value and a sign of low solvency as CRNT would need 7.68 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 7.68, CRNT perfoms like the industry average, outperforming 48.94% of the companies in the same industry.
  • A Debt/Equity ratio of 0.18 indicates that CRNT is not too dependend on debt financing.
  • CRNT's Debt to Equity ratio of 0.18 is in line compared to the rest of the industry. CRNT outperforms 40.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 7.68
Altman-Z 1.41
ROIC/WACC0.76
WACC9.11%
CRNT Yearly LT Debt VS Equity VS FCFCRNT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

  • CRNT has a Current Ratio of 1.81. This is a normal value and indicates that CRNT is financially healthy and should not expect problems in meeting its short term obligations.
  • CRNT has a worse Current ratio (1.81) than 65.96% of its industry peers.
  • A Quick Ratio of 1.36 indicates that CRNT should not have too much problems paying its short term obligations.
  • CRNT has a worse Quick ratio (1.36) than 65.96% of its industry peers.
Industry RankSector Rank
Current Ratio 1.81
Quick Ratio 1.36
CRNT Yearly Current Assets VS Current LiabilitesCRNT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2

3. CRNT Growth Analysis

3.1 Past

  • The earnings per share for CRNT have decreased strongly by -75.61% in the last year.
EPS 1Y (TTM)-75.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-77.78%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-23.01%

3.2 Future

  • Based on estimates for the next years, CRNT will show a very strong growth in Earnings Per Share. The EPS will grow by 48.34% on average per year.
  • CRNT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.87% yearly.
EPS Next Y65.75%
EPS Next 2Y50.56%
EPS Next 3Y48.34%
EPS Next 5YN/A
Revenue Next Year7.05%
Revenue Next 2Y6.87%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

CRNT Yearly Revenue VS EstimatesCRNT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
CRNT Yearly EPS VS EstimatesCRNT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.1 -0.1 0.2 0.3 0.4

6

4. CRNT Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 22.25, which indicates a rather expensive current valuation of CRNT.
  • 72.34% of the companies in the same industry are more expensive than CRNT, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 26.17. CRNT is around the same levels.
  • CRNT is valuated correctly with a Price/Forward Earnings ratio of 13.42.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CRNT indicates a rather cheap valuation: CRNT is cheaper than 91.49% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of CRNT to the average of the S&P500 Index (23.05), we can say CRNT is valued slightly cheaper.
Industry RankSector Rank
PE 22.25
Fwd PE 13.42
CRNT Price Earnings VS Forward Price EarningsCRNT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CRNT indicates a rather cheap valuation: CRNT is cheaper than 97.87% of the companies listed in the same industry.
  • CRNT's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 49.52
EV/EBITDA 4.2
CRNT Per share dataCRNT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • CRNT's earnings are expected to grow with 48.34% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.34
PEG (5Y)N/A
EPS Next 2Y50.56%
EPS Next 3Y48.34%

0

5. CRNT Dividend Analysis

5.1 Amount

  • No dividends for CRNT!.
Industry RankSector Rank
Dividend Yield 0%

CRNT Fundamentals: All Metrics, Ratios and Statistics

CERAGON NETWORKS LTD

NASDAQ:CRNT (4/6/2026, 9:53:41 AM)

2.225

+0.04 (+1.6%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)02-17
Earnings (Next)05-05
Inst Owners19.3%
Inst Owner Change0%
Ins Owners13.85%
Ins Owner Change6.57%
Market Cap200.01M
Revenue(TTM)N/A
Net Income(TTM)1.39M
Analysts81.67
Price Target4.85 (117.98%)
Short Float %0.27%
Short Ratio0.49
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-30.52%
Min EPS beat(2)-35.18%
Max EPS beat(2)-25.86%
EPS beat(4)1
Avg EPS beat(4)-12.46%
Min EPS beat(4)-35.18%
Max EPS beat(4)17.65%
EPS beat(8)4
Avg EPS beat(8)4.5%
EPS beat(12)6
Avg EPS beat(12)8.41%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-5.56%
Min Revenue beat(2)-11.53%
Max Revenue beat(2)0.4%
Revenue beat(4)2
Avg Revenue beat(4)-2.82%
Min Revenue beat(4)-11.53%
Max Revenue beat(4)0.4%
Revenue beat(8)3
Avg Revenue beat(8)-1.75%
Revenue beat(12)6
Avg Revenue beat(12)-0.89%
Revenue beat(16)6
Avg Revenue beat(16)-1.33%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-33.33%
EPS NY rev (1m)0%
EPS NY rev (3m)-10.47%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.61%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.65%
Valuation
Industry RankSector Rank
PE 22.25
Fwd PE 13.42
P/S 0.55
P/FCF 49.52
P/OCF 9.23
P/B 1.16
P/tB 1.45
EV/EBITDA 4.2
EPS(TTM)0.1
EY4.49%
EPS(NY)0.17
Fwd EY7.45%
FCF(TTM)0.04
FCFY2.02%
OCF(TTM)0.24
OCFY10.83%
SpS4.04
BVpS1.91
TBVpS1.54
PEG (NY)0.34
PEG (5Y)N/A
Graham Number2.08
Profitability
Industry RankSector Rank
ROA 0.43%
ROE 0.81%
ROCE 11.64%
ROIC 6.9%
ROICexc 8.5%
ROICexgc 10.39%
OM 6.32%
PM (TTM) 0.38%
GM 34.98%
FCFM 1.11%
ROA(3y)0.75%
ROA(5y)-1.82%
ROE(3y)0.89%
ROE(5y)-3.97%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y93.38%
ROICexgc growth 5Y31.98%
ROICexc growth 3Y86.61%
ROICexc growth 5Y29.42%
OM growth 3Y71.41%
OM growth 5Y22.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.77%
GM growth 5Y0.06%
F-Score5
Asset Turnover1.11
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 7.68
Debt/EBITDA 0.85
Cap/Depr 129.1%
Cap/Sales 4.85%
Interest Coverage 250
Cash Conversion 59.18%
Profit Quality 290.37%
Current Ratio 1.81
Quick Ratio 1.36
Altman-Z 1.41
F-Score5
WACC9.11%
ROIC/WACC0.76
Cap/Depr(3y)125.95%
Cap/Depr(5y)101.34%
Cap/Sales(3y)4.03%
Cap/Sales(5y)3.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-75.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-77.78%
EPS Next Y65.75%
EPS Next 2Y50.56%
EPS Next 3Y48.34%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-23.01%
Revenue Next Year7.05%
Revenue Next 2Y6.87%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-41.62%
EBIT growth 3Y89.71%
EBIT growth 5Y30.47%
EBIT Next Year-27.61%
EBIT Next 3Y1.21%
EBIT Next 5YN/A
FCF growth 1Y1102.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y89.73%
OCF growth 3YN/A
OCF growth 5YN/A

CERAGON NETWORKS LTD / CRNT Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CERAGON NETWORKS LTD (CRNT) stock?

ChartMill assigns a fundamental rating of 3 / 10 to CRNT.


What is the valuation status for CRNT stock?

ChartMill assigns a valuation rating of 6 / 10 to CERAGON NETWORKS LTD (CRNT). This can be considered as Fairly Valued.


What is the profitability of CRNT stock?

CERAGON NETWORKS LTD (CRNT) has a profitability rating of 4 / 10.


Can you provide the financial health for CRNT stock?

The financial health rating of CERAGON NETWORKS LTD (CRNT) is 3 / 10.


Can you provide the expected EPS growth for CRNT stock?

The Earnings per Share (EPS) of CERAGON NETWORKS LTD (CRNT) is expected to grow by 65.75% in the next year.